Comparison

Ricolinostat European Partner

Item no. HY-16026-10mM
Manufacturer MedChem Express
CASRN 1316214-52-4
Amount 10mM/1mL
Quantity options 100 mg 10mM/1mL 10 mg 50 mg 5 mg
Category
Type Inhibitors
Clone N/A
Specific against other
Purity 99.83
Formula C24H27N5O3
Citations [1]Santo L, et al. Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with PS-341 in multiple myeloma. Blood. 2012 Mar 15;119(11):2579-89.
Smiles O=C(C1=CN=C(N(C2=CC=CC=C2)C3=CC=CC=C3)N=C1)NCCCCCCC(NO)=O
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias ACY-1215; Rocilinostat
Shipping Condition Room temperature
Available
Manufacturer - Type
Reference compound
Manufacturer - Applications
Cancer-programmed cell death
Manufacturer - Targets
Apoptosis; HDAC
Shipping Temperature
Room Temperature
Storage Conditions
4°C (Powder, stored under nitrogen)
Molecular Weight
433.50
Product Description
Ricolinostat (ACY-1215) is a potent and selective HDAC6 inhibitor, with an IC50 of 5 nM. ACY-1215 also inhibits HDAC1, HDAC2, and HDAC3 with IC50s of 58, 48, and 51 nM, respectively.
Manufacturer - Research Area
Cancer
Solubility
DMSO : ≥ 50 mg/mL
Manufacturer - Pathway
Apoptosis; Cell Cycle/DNA Damage; Epigenetics
Isoform
HDAC1; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8
Clinical information
Phase 2

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10mM/1mL
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close